Revolution Medicines Inc. Warrant (RVMDW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Revolution Medicines Inc. Warrant, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Revolution Medicines Inc. Warrant (RVMDW) has returned 90.45% so far this year and 4,610.53% over the past 12 months.

Based on dividend-adjusted daily data since Nov 17, 2023, RVMDW's average daily return is +1.81%, while the average monthly return is +17.84%. At this rate, your investment would double in approximately 0.4 years.

Historically, 52% of months were positive and 48% were negative. The best month was Jun 2025 with a return of +148.5%, while the worst month was Mar 2025 at -55.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 4 months.

On a daily basis, RVMDW closed higher 42% of trading days. The best single day was May 23, 2025 with a return of +153.5%, while the worst single day was May 27, 2025 at -50.0%.

Revolution Medicines Inc. Warrant has an annualized alpha of 6856.63%, beta of 1.60, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since November 20, 2023.

• This stock captured 89.36% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -28.17%) — a profile typical of hedging or uncorrelated assets.
• R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

RVMDW ranks 99 for risk / return — in the top 99% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Revolution Medicines Inc. Warrant (RVMDW) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Revolution Medicines Inc. Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Revolution Medicines Inc. Warrant was 96.90%, occurring on Apr 10, 2025. Recovery took 186 trading sessions.

The current Revolution Medicines Inc. Warrant drawdown is 47.66%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Revolution Medicines Inc. Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Revolution Medicines Inc. Warrant is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.